期刊文献+

VA5免疫增强剂对鸽新城疫病毒灭活疫苗的增效作用研究 被引量:4

Study on Synergistic Effect of VA5 Immunopotentiator on Pigeon NDV Inactivated Vaccine
下载PDF
导出
摘要 试验旨在探究VA5免疫增强剂对鸽新城疫病毒(NDV)灭活疫苗(ND4416株)的免疫增效作用。选取160只健康鸽随机分为4组:ND4416株灭活疫苗组(NDV组)、ND4416株灭活疫苗与免疫增强剂(VA5)混合组(NDV+VA5组)、La Sota灭活疫苗组(La Sota组)及生理盐水空白对照组(C组),进行免疫效力及免疫持续期试验。采用血凝抑制试验检测各组鸽免疫后不同时间点的血清抗体效价,结果显示,VA5免疫增强剂能够显著提高鸽NDV灭活疫苗血清抗体水平(P<0.05)。脾脏淋巴细胞转化试验结果显示,VA5能够有效刺激免疫鸽的淋巴细胞转化。在免疫后第30、90、180天,各组鸽子采用ND4416株进行攻毒试验,结果显示,NDV+VA5组在3个时间点的攻毒保护率均为100%,均高于La Sota组。免疫持续期试验结果显示,NDV+VA5组血清抗体水平在免疫后第21天达峰值11.20log2,第180天仍能达到7.50log2,攻毒保护率达100%,表明VA5免疫增强剂可延长鸽新城疫疫苗的免疫效力持续期至180 d。攻毒后体外排毒检测结果表明,VA5免疫增强剂能够缩短攻毒后鸽的体外排毒周期,减少体外排毒。综上,VA5免疫增强剂能够显著提高鸽NDV灭活疫苗的免疫效果,为研制效果更好的鸽NDV疫苗提供了基础依据,同时也为免疫增强剂的应用增加了试验数据。 This study was designed to evaluate the synergistic effect of VA5 immunopotentiator on pigeon ND4416 inactivated vaccine.160 healthy pigeons were randomly divided into four groups,including ND4416 strain inactivated vaccine group(NDV group),ND4416 strain inactivated vaccine and immunopotentiator(VA5)mixed group(NDV+VA5 group),La Sota inactivated vaccine group(La Sota group)and normal saline as the control group(C group),to assess their vaccine efficacy against virulent pigeon NDV by serological analysis and animal testing.Pigeons sera were collected at different time points after immunization and measured the HI antibody titer of each group.The results showed that VA5 immunopotentiator significantly improved the serum antibody level of pigeons immunized with pigeon Newcastle disease inactivated vaccine(P<0.05).In addition,comparative test of spleen lymphocyte transformation was conducted at various time points after immunization.The results indicated that VA5 effectively stimulated the lymphocyte transformation of immune pigeon.Pigeons in each groups were challenged with ND4416 strain at the 30th,90th and 180th d after immunization.The results presented that the NDV+VA5 group had 100%protection rate and higher than La Sota group.The duration of immunization test showed that the antibody titer of NDV+VA5 group reached peak 11.20log2 at the 21st d,remained 7.50log2 at 180th d,and the protection rate remained 100%at 180th d.It indicated that VA5 immunopotentiator sustained the immune duration of pigeon NDV vaccine up to 180 d.Moreover,the in vitro detoxification test results suggested that VA5 immunopotentiator reduced the in vitro detoxification cycle of pigeons after challenge.Overall,this study suggested VA5 immunopotentiator could significantly improve the immune efficacy of pigeon Newcastle disease inactivated vaccine,which provided a basis for further enhancing the efficacy of Newcastle disease vaccine,as well increased experimental data for the application of immunopotentiators.
作者 熊晓妍 覃振斌 莫红芳 何东贤 虞霖田 许家荣 XIONG Xiaoyan;QIN Zhenbin;MO Hongfang;HE Dongxian;YU Lintian;XU Jiarong(Guangxi Agricultural Vocational College,Nanning 530007,China;Guangxi University,Nanning 530004,China;Nanjing Agricultural University,Nanjing 210095,China)
出处 《中国畜牧兽医》 CAS 北大核心 2020年第12期4032-4040,共9页 China Animal Husbandry & Veterinary Medicine
基金 2020年广西高校中青年教师科研基础能力提升项目“益生菌对鸽新城疫灭活疫苗的协同增效作用研究”(2020KY36016) 广西农业职业技术学院科学研究与技术开发项目(YKJ1916) 南京农业大学高校产学研合作创新项目(NAU201504-01)。
关键词 新城疫病毒灭活疫苗 ND4416株 VA5免疫增强剂 免疫效力 pigeon Newcastle disease virus inactivated vaccine ND4416 strain VA5 immunopotentiator immune efficacy
  • 相关文献

参考文献9

二级参考文献66

  • 1刘华雷,周斌,郁斌,王永坤,陈溥言.五株鸽副粘病毒国内分离株F基因片段的克隆与分子特性[J].病毒学报,2004,20(4):378-381. 被引量:11
  • 2刘文斌,崔尚金,李秀云,刘立奎,张洪英.新城疫病毒分离株APMV1/chicken/China/JL-11/02的致病性研究[J].中国兽医杂志,2005,41(5):8-10. 被引量:11
  • 3杨吉才,石国芳.鸽新城疫最新研究进展[J].中国动物保健,2005,7(9):34-36. 被引量:11
  • 4王晓丽,夏兴霞,赵永前,褚玉梅,戴鼎震.鸽新城疫油乳剂灭活疫苗的研制[J].江苏农业学报,2007,23(2):109-113. 被引量:3
  • 5崔晓萍,秦爱建,崔治中,郑明,王静兰.鸽新城疫病毒的分离及鸽群自然感染状况的调查[J].中国兽药杂志,1997,31(2):6-10. 被引量:33
  • 6Alexander D J., Russeil P H., Parsons G. , et al. Antigenic and biological characterization of paramyxovirus type 1 isolstes from pigeon -an international collaborative study[J ]. Avian Pat hology, 1985, 14:365--376.
  • 7ALEXANDER D J,PARSONS G.Avian paramyxovims type Ⅰ infections of racing pigeons:2 pathogenicity experiments in pigeons and chickens[J].The Veterinary Record,1984,114(19):466-469.
  • 8KHURANA S,CHEARWAE W,CASTELLINO F,et al.Vac-cines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus [ J].Sci Transl Med,2010,2(15):15.
  • 9REYNALES H,ASTUDILLO P,DE VALLIERE S,et al.A pro-spective observational safety study on MF59 adjuvanted cell culture-derived vaccine,Cehura during the A/H1 N1(2009)influenza pandemic [J].Vaccine,2012,30(45):6436-6443.
  • 10PULESTON R,BUGG G,HOSCHLER K,et al.Multi-centre ob-servational study of transplacental transmission of influenza anti-bodies following vaccination with AS03(A)-adjuvanted H1 N1 2009 vaccine [J].PLoS One,2013,8(1):e47448.

共引文献53

同被引文献62

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部